Although OpenMTA can be used as an integrated agreement, the online version of OpenMTA is structured as a framework agreement that can be approved at the institutional level. The online framework agreement ensures consistency in the use of the OpenMTA (i.e. no change in terms or edition) and also ensures transparency for the people and institutions that have become signatories (i.e. signatories can be listed online for easy reference). Once an institution has signed the OpenMTA Framework Agreement, transfers can be made with an implementation letter. This simplifies the material transfer process by not requiring the review of conditions and providing the documentation required for provenance tracking. The Open Material Transfer Agreement is a material transfer agreement that allows for the wider sharing and exploitation of biological material by biotechnology practitioners working in the practical realities of technology transfer. Here we present a new MTA, the Open Material Transfer Agreement (OpenMTA), which eases restrictions on the redistribution and commercial use of biomaterials while retaining aspects of standard ATMs that promote wide adoption (e.B. integration into semi-automatic management systems). In developing openMTA, our motivation was to create a simple and standardized legal tool to share biological material as widely as possible without undue restrictions, while respecting copyrights and promoting safe practices and responsible research. It is important to know whether the tool fits into the practical realities of technology transfer and is flexible enough to meet the needs of many groups around the world (e.g. B support for international transfers and compatibility with public and philanthropic funding policies).

The design objectives of the OpenMTA reflect the principles of “openness” set out in the Open Definition (opendefinition.org/). These design objectives, along with additional objectives to ensure safety and enable the sharing of biomaterials in an international context, were used to lead the drafting of the OpenMTA legal text. Use of model agreements A long-recognized strategy to reduce costs and negotiation time is the use of standard or model agreements. In 1995, the NIH published the first and only widely accepted model agreements for the transfer of materials, the NIH Simple Letter Agreement for the Transfer of Materials (SLA) and the Uniform Biological Material Transfer Agreement (UBMTA), as well as guidelines for the transfer of research tools. The NIH urged fellows to ensure that the unique research resources resulting from NIH-funded research are made available to the scientific research community, either without formal agreement or under conditions or agreements that are no more restrictive for most materials than ALS. a renewed call by NRC. This article is licensed under the Creative Commons Attribution 4.0 International License, which allows the use, sharing, adaptation, distribution, and reproduction in any medium or format, provided that the original author(s) and source are correctly indicated, that a link to the Creative Commons license is provided, and that any changes have been made. Images or other third-party materials in this article are included in the creative commons license of the article, unless otherwise specified in a line of credit for the material. If the material is not included in the Creative Commons license of the article and its intended use is not permitted by law or exceeds the permitted use, you must obtain permission directly from the copyright owner.

To view a copy of this license, visit creativecommons.org/licenses/by/4.0/ A Material Transfer Agreement (MTA) is a legal contract used to document the transfer of physical material between Yale University and academic, non-profit or industrial institutions. .